A side-by-side comparison of Brahmi churna and Shankhpushpi churna for brand owners and formulators choosing between these two Medhya Rasayana herbs.
Brahmi churna and Shankhpushpi churna occupy the same cognitive-support segment in Ayurvedic formulation, but they come from different botanical sources, carry distinct classical text references and behave differently across finished-product formats. Choosing between them calls for a clear look at botanical identity, pharmacopoeial markers and the product licence your brand holds.
Brahmi is most widely understood as Bacopa monnieri, a creeping aquatic herb documented across classical Ayurvedic formulations. A naming ambiguity worth noting: in some regional traditions the name Brahmi is applied to Centella asiatica, which is sold separately as Mandukparni. When sourcing Brahmi churna for a licensed Ayurvedic product, confirm the botanical name on the certificate of analysis and ensure it matches the species named in your approved formulation.
Shankhpushpi refers to Convolvulus pluricaulis, a trailing herb with pale blue flowers found across the Indian subcontinent. The Ayurvedic Pharmacopoeia of India specifies Convolvulus pluricaulis as the accepted species, though Evolvulus alsinoides and Clitoria ternatea are used in regional practice under the same name. Botanical verification at source protects your formulation from species substitution and the regulatory complications that follow.
Both herbs appear in the Medhya Rasayana category of classical Ayurvedic texts, which groups formulations associated with cognitive and nervous system support in the traditional literature. Brahmi is referenced in Charaka Samhita and Sushruta Samhita among Medhya dravyas. Shankhpushpi appears prominently in Ashtanga Hridayam and Bhaishajya Ratnavali in formulations associated with memory support and mental clarity.
The distinction that matters to a formulator is that the texts sometimes use these herbs together in compound formulations and sometimes independently. If your product references a named classical compound from the Ayurvedic Formulary of India, the specific herb or combination is already fixed by the monograph. For proprietary products, the choice requires deliberate specification against your licence scope.
| Parameter | Brahmi (Bacopa monnieri) | Shankhpushpi (Convolvulus pluricaulis) |
|---|---|---|
| Plant part specified | Aerial parts, whole plant | Whole plant including root |
| Classical category | Medhya Rasayana | Medhya Rasayana |
| Taste profile | Bitter, astringent | Sweet, astringent, bitter |
| Key pharmacopoeial marker | Bacosides (HPLC identification) | Shankhpushpin, scopoletin |
| Primary adulteration risk | Centella asiatica substitution | Evolvulus alsinoides mixing |
| Common finished forms | Churna, tablet, syrup, capsule | Churna, classical syrup, tablet |
Both herbs are available in the single herb churna range from Raasa Ayurveda, supplied as batch-tested powder with pharmacopoeial documentation.
For Brahmi churna, request HPLC identification of bacosides against a reference standard as the primary identity confirmation. The Ayurvedic Pharmacopoeia of India also specifies ash value, acid-insoluble ash, loss on drying and microbial limits. Adulteration with Centella asiatica is commercially motivated where Mandukparni commands a lower price; HPLC or TLC testing reliably distinguishes the two species.
For Shankhpushpi churna, pharmacopoeial testing covers ash values, loss on drying and microbial limits. A TLC or HPLC fingerprint comparing the batch against an authenticated Convolvulus pluricaulis reference provides defensible documentation for both domestic and export regulatory purposes. Species verification is particularly important given the multiple plants used regionally under this name.
In both cases, heavy metal testing for arsenic, lead, cadmium and mercury is a Schedule T requirement. The certificate of analysis should quote actual batch-specific numerical values, not simply a statement of compliance.
Beyond identity and purity, specify mesh size for both herbs in your purchase order. Material used in tablet granulation typically requires 60 to 80 mesh; capsule filling may require finer powder but that increases moisture uptake risk during storage. Request a sieve analysis report with each batch and verify that the supplier can hold the mesh specification consistently across consecutive deliveries.
Brahmi churna is well suited to standalone single-herb churna, compound Medhya Rasayana formulations, and as an input material for tablet and capsule formats. Its bitter taste makes incorporation at high quantities in oral syrups difficult without taste-masking measures.
Shankhpushpi churna has a long classical association with liquid preparations. The Shankhpushpi syrup described in classical texts combines the herb with other Medhya dravyas in a sweetened liquid vehicle, and the herb's palatability in this format compares favourably with Brahmi at equivalent concentrations. For brands formulating a cognitive-support syrup, Shankhpushpi is often the more practical primary ingredient.
Both herbs can be combined in the same formulation where the classical reference supports it. Verify with your contract manufacturing partner whether the combination and its ratio fall within the scope of your existing product licence.
If your product references a specific classical formulation from the Ayurvedic Formulary of India, the herb is specified and the decision is already made. For proprietary products, format, dose and market positioning determine the better fit. A syrup targeting a domestic brand may favour Shankhpushpi. A tablet or capsule targeting export markets may favour Brahmi with a declared bacoside level.
Request samples of both herbs from your bulk supply partner before committing to a batch. Compare the certificates of analysis for botanical identity confirmation, pharmacopoeial test results and mesh specification. Pricing for both herbs varies with growing season outcomes, raw material availability and the processing steps required to reach your specified mesh and moisture targets. Confirm pricing against a written specification rather than a general catalogue rate; a supplier who quotes against a defined specification is far more useful as a long-term input material partner.
To discuss Brahmi or Shankhpushpi churna sourcing, request samples or explore compound formulation options, contact Raasa Ayurveda in Kanpur at raasaayurveda@gmail.com or on +91 9415128217.
No. In the Ayurvedic Pharmacopoeia of India, Brahmi refers to Bacopa monnieri. Gotu Kola is Centella asiatica, known in Ayurveda as Mandukparni. The two are botanically distinct and are not interchangeable in a licensed formulation. Confirm which species is specified in your product approval before placing a sourcing order for Brahmi churna.
Yes. Classical texts include compound formulations that combine both herbs. If your product references a named classical compound, the ratio is fixed by the Ayurvedic Formulary of India monograph. For proprietary blends, verify that the combination and its ratio fall within your AYUSH product licence scope before proceeding to production.
The primary risk is species substitution: Evolvulus alsinoides and Clitoria ternatea are sold under the Shankhpushpi name in different regions. Confirm botanical identity through TLC or HPLC fingerprinting against an authenticated Convolvulus pluricaulis reference standard. Ask your supplier to provide method details alongside the result so your QC team can assess the quality of the identification.
State the botanical name (Bacopa monnieri), plant part (aerial parts, whole plant), required mesh size and the pharmacopoeial reference (Ayurvedic Pharmacopoeia of India). Request a certificate of analysis with HPLC bacoside identification, ash values, heavy metal data and microbial test results for each batch. This documentation set protects your QC process and supports any downstream regulatory review.
Raasa Ayurveda, 49/72-A, Naughara, Kanpur 208001, Uttar Pradesh, India. Telephone +91 9415128217. Email raasaayurveda@gmail.com.